Covid-19疫苗包装和送货装置市场份额，规模，趋势，行业分析报告，由产品（小瓶，注射器）;通过包装（绝缘托运人，绝缘容器，制冷剂）;按地区;分部预测，2021 - 2028

报告摘要

The global COVID-19 vaccine packaging and delivery devices market was valued at USD 1.9 million in 2020 and is expected to grow at a CAGR of 20.1% during the forecast period. Accelerating rollouts, broadening manufacturing capability and a large number of vaccines in the final phase of clinical approval are some of the key factors in the global market growth for COVID-19 vaccine packaging and delivery devices during the forecast period.

了解有关此报告的更多信息：请求样本页面

Manufacturers are increasing their production capacity in order to meet rising global market demand for COVID-19 vaccine packaging and delivery devices. The increased capacity is projected to augment the market demand for packaging materials. For Instance, in March 2021, Biomedical Advanced Research and Development Authority (BARDA) approved USD 204 million funding for Corning Incorporated.

这是扩大康宁瓦尔玻璃瓶的国内制造能力，用于携带植物疫苗的包装包装。由于R＆D的投资增加，进一步预计对Covid-19疫苗包装和送货装置的市场需求进一步扩大，以改善在材料强度和化学稳定性方面更好的包装材料。

Industry Dynamics

成长司机
Covid-19是自19世纪初自美西方流感以来影响世界的主要健康危机。全球诊断出超过1.45亿电晕案例。目前，市场上没有有效的药物来治愈疾病，但只有少数抗病毒药物如雷德尔毒性药物用于科迪德症状的管理。

疫苗似乎是唯一能解决这种大流行和去年的解决方案，全球各地的许多公司正在开发接种。这些疫苗中的大多数需要储存在低温下，并且需要在特定类型的材料中包装。这有望推动Covid-19疫苗包装和送货设备的全球市场的增长。

目前，在全球各地的不同国家批准了几种接种，包括来自辉瑞和Biontech（Tozinameran或Bnt162B2），Astrazeneca（Vaxzevria或Covishield），Bharat Biotech（Covaxin），Gamaleya研究所（Sputnik V），Modera（mRNA-1273）和Sinovac（Coronavac）。这些血清中的大多数需要在玻璃瓶中包装并在2℃至8℃下储存以保持它们的功效。

There are several new inoculations which are in pipeline that includes vaccines from Novavax (NVX-CoV2373), Zydus Cadila (ZyCoV-D), Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) (Abdala (CIGB 66)), Medicago (VIR-7831), CureVac (CVnCoV), Murdoch Children’s Research Institute (Bacillus Calmette-Guerin), Inovio Pharmaceuticals (INO-4800), ImmunityBio (hAd5), Vaxxinity (UB-612), and ReiThera, Leukocare & Univercells (GRAd-COV2).

Countries across the globe are ordering a huge number of serums to vaccinate a greater number of people as early as possible. Recently, UK entered into a deal with Pfizer to purchase tens of millions more doses of its serums to give a third booster dose for its elderly population.

美国政府还订购了1亿剂的现代疫苗，于2021年2月，除了已经订购的3亿剂。该公司预计将于7月2021年底递送剂量。全球射击产量越来越多，将成为市场增长的主要推动力。

需要评估几个新的菌株，如印度，英国，巴西和非洲等国家，以及批准的血清对这些菌株的疗效需要进行评估。如果可用的接种对新菌株无效，则需要开发新的血清候选人，这些血清候选人可以为未来增长的Covid-19疫苗包装和送货设备提供全球市场的机会。

关于引入新的包装材料和送货装置，发生了很多新的发展。例如，在5月2020年5月，亚联符公司与Pharmajet合作进行交付系统。根据合作伙伴，Pharmajet将提供无针注射技术，以递送亚联符的mRNA疫苗。

阿斯利康联手IDT Biologika、蒙古包man contract research manufacturer, in February 2021, to establish a new manufacturing facility for the production and filling of glass vials. Moderna, Inc. and Catalent, Inc. entered into a partnership, in 2020 under which Catalent will provide vial filling and packaging capacity for the production of Moderna’s serum.

COVID-19 Vaccine Packaging and Delivery Devices Market Research Scope

该市场主要基于产品，包装和地区进行分段。

由产品	通过包装	By Region
小瓶 Syringes	Insulated Shippers Insulated Containers 制冷剂	北美（美国，加拿大） 欧洲（法国，德国，意大利，荷兰，英国，俄罗斯，西班牙，奥地利） Asia Pacific (China, India, Japan, Indonesia, Malaysia, South Korea) Latin America (Argentina, Brazil, Mexico) 中东和非洲（沙特阿拉伯，以色列，阿联酋，南非）

了解有关此报告的更多信息：请求样本页面

Insight by Product

注射器段在2020年占据了市场并产生了Covid-19疫苗包装和送货装置行业的最高收入。空和预填充注射器进一步从注射器市场分段。将单个Covid-19剂量的平均体积计算为0.5ml，因此优选具有1.0mL容量的无菌空注射器。

Furthermore, certain candidates must be reconstituted with diluent solutions before use, necessitating the use of an additional empty syringe (2/3 ml). Pfizer has designed a serum that must be reconstituted with saline; as a result, the speed of the roll-out program is anticipated to have a substantial impact on the market segment.

在预测时代，预先填写的注射器部分预计将以最快的步伐上升。通过现有的物流网络，在较短的时间内接种世界的人口70亿人口是一个繁琐的过程。预计目前的Covid-19包装系统的分配限制以增加对这些注射器的偏好。例如，Becton，Dickinson和公司于2020年12月投资12亿美元，以提高预先填充注射器的制造能力。

Geographic Overview

North America COVID-19 vaccine packaging and delivery devices is expected accounted for the largest revenue share of the global market during the forecast period. Over 32 million people are diagnosed with COVID-19 in the U.S. alone and hence the country investing heavily and fast-tracking the approval of the serum so that most of the population is vaccinated at the earliest.

Several new serums are approved in the U.S. including indigenously produced vaccines from Pfizer and Moderna. Even Novavax which is based in the U.S. is going to launch its inoculation soon in the market. More than 231 million doses of vaccines are administered in the U.S. alone.

Asia Pacific COVID-19 vaccine packaging and delivery devices market is projected to be the fastest-growing region in the global market over the study period. India is among the worst-hit COVID-19 country belong to this region. India is the largest manufacturer of the product in the world. Also because of the population of China and India, this region is anticipated to require more shots.

最近印度废除了桥梁临床试验，以批准美国和欧洲已经批准的血清。最近印度政府宣布超过4300万Covid-19疫苗剂量有库存或管道。该国已经提供了两种血清，在5月，俄罗斯接种预计进入Covid-19疫苗包装和送货设备市场。

竞争洞察力

全球各地的几家制药公司甚至政府都在大大投资Covid-19疫苗的生产。对产品的需求巨大的需求，因此公司正在与其他公司进入合作伙伴关系，该公司为生产设施包括外包或在包装和交付设备中的合作。

Some of the major players operating in the COVID-19 vaccine packaging and delivery devices market include B. Braun Melsungen AG, Terumo, Becton, Dickinson and Company, Hindustan Syringes & Medical Devices Ltd., SCHOTT AG, Cardinal Health, NIPRO Medical Corporation, and Gerresheimer AG.